2026 NPPES data Advanced Heart Failure and Transplant Cardiology Physician NPI 1427071349 M.D.
Verify on CMS →

MOHAMMAD ABUANNADI, M.D.

Advanced Heart Failure and Transplant Cardiology Physician in CHARLOTTESVILLE, Virginia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 219 beneficiaries · Advanced Heart Failure and Transplant Cardiology Physician avg: 2K
Generic prescribing
78%
generic claims · 22% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.3949/100
▼ 4 pts below national avg 83.1 · [object Object]
Industry payments
$139.5
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MOHAMMAD ABUANNADI, M.D. is a Advanced Heart Failure and Transplant Cardiology Physician ([object Object]) practicing in CHARLOTTESVILLE, Virginia with a Medicare Part D prescribing footprint of 2K claims across 219 beneficiaries — 22% brand-name prescribing . Their CMS MIPS Final Score of 79.3949/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $139.5 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MOHAMMAD ABUANNADI, M.D. reported a CMS MIPS final score of 79.3949 out of 100, below the 83.1 national average, and filed 1,946 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MOHAMMAD ABUANNADI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MOHAMMAD ABUANNADI, M.D. at a glance

Near national average

NPI registry status

Active

Issued 07/25/2006

NPI 1427071349

Primary specialty

Advanced Heart Failure and Transplant Cardiology Physician

Niche

510 US NPIs in this specialty

Medicare Part D claims

1,946 10% vs specialty avg

2023 prescription claims

Specialty avg: 1,762

MIPS final score

79.3949/100 3.7050999999999874% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Virginia

How Advanced Heart Failure and Transplant Cardiology Physician compares to other specialties among Virginia providers

Virginia providers

Advanced Heart Failure and Transplant Cardiology Physician share within Virginia

1. Advanced Heart Failure and Transplant Cardiology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Advanced Heart Failure and Transplant Cardiology Physician share within Virginia

Medicare quality performance — MIPS

MOHAMMAD ABUANNADI, M.D.'s 2023 MIPS final score plotted against the Advanced Heart Failure and Transplant Cardiology Physician national average

Near national average
MIPS Final Score
79.3949/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Advanced Heart Failure and Transplant Cardiology Physician) — 79.3949/100 vs national avg 83.1

0%100%National avg83%79.4%
MIPS final score (Advanced Heart Failure and Transplant Cardiology Physician) — 79.3949/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MOHAMMAD ABUANNADI, M.D. is a Advanced Heart Failure and Transplant Cardiology Physician provider practicing in CHARLOTTESVILLE, Virginia, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1427071349. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MOHAMMAD ABUANNADI, M.D. appears in the CMS NPPES registry as a Advanced Heart Failure and Transplant Cardiology Physician provider holding M.D. credentials at 500 RAY C. HUNT DR, CHARLOTTESVILLE, VA, 22903, with a listed phone of (434) 243-1000. NPI 1427071349 was issued on 07/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ABUANNADI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,946 prescription claims written by this provider, covering 219 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 22% brand-name and 78% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.3949/100 for the 2023 performance year (Quality 73.6607, Cost 57.6556), compared with the national average of 83.1.

Advanced Heart Failure and Transplant Cardiology Physician is a narrow specialty nationwide, with 510 enrolled providers across 48 states and an average of 1,762 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

500 RAY C. HUNT DR
CHARLOTTESVILLE, VA 22903

Provider Details

NPI 1427071349
Specialty Advanced Heart Failure and Transplant Cardiology Physician
Credentials M.D.
Gender Male
NPI Issued 07/25/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

79.3949
Final Score
Avg: 83.1
73.6607
Quality
57.6556
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MOHAMMAD ABUANNADI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF VIRGINIA PHYSICIANS GROUP
CHARLOTTESVILLE, VA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MOHAMMAD ABUANNADI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$140

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MOHAMMAD ABUANNADI, M.D. — brand share 22.0%
Specialty average (est.)

22% brand-name claims vs 78% generic, on 1,946 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,946
Total Claims
$1.1M
Total Drug Cost
219
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,516
Total Day Supply
134,280
Brand vs Generic
22% brand / 78% generic
Brand Drug Cost
$1.0M
Generic Drug Cost
$37K
Antibiotic Claims
12

Patient Demographics

Average Patient Age
68.4 years
Avg HCC Risk Score
2.47
Gender Split
37% female / 63% male
Age Distribution
<65: 64, 65-74: 94, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Metoprolol Succinate
247
Spironolactone
159
Atorvastatin Calcium
153
Furosemide
140
Entresto
Sacubitril/Valsartan
120
Carvedilol
112
Lisinopril
112
Farxiga
Dapagliflozin Propanediol
109
Eliquis
Apixaban
102
Amlodipine Besylate
75

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Advanced Heart Failure and Transplant Cardiology Physician Overview

How MOHAMMAD ABUANNADI, M.D. fits within the Advanced Heart Failure and Transplant Cardiology Physician landscape nationally.

510
Advanced Heart Failure and Transplant Cardiology Physician Providers in US
48
States with Advanced Heart Failure and Transplant Cardiology Physician
1,762
Avg Claims per Provider

MOHAMMAD ABUANNADI, M.D.'s 1,946 claims are above the specialty average of 1,762.

Nearby Advanced Heart Failure and Transplant Cardiology Physician Providers in Virginia

Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as ABUANNADI.

Compare Advanced Heart Failure and Transplant Cardiology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MOHAMMAD ABUANNADI, M.D.'s specialty?
MOHAMMAD ABUANNADI, M.D. specializes in Advanced Heart Failure and Transplant Cardiology Physician and practices in CHARLOTTESVILLE, Virginia. Credentials: M.D..
How much does MOHAMMAD ABUANNADI, M.D. prescribe under Medicare Part D?
In 2023, MOHAMMAD ABUANNADI, M.D. wrote 1,946 Medicare Part D claims totaling $1.1M in drug costs for 219 beneficiaries.
What is MOHAMMAD ABUANNADI, M.D.'s Medicare quality score?
MOHAMMAD ABUANNADI, M.D. has a CMS MIPS Final Score of 79.3949/100 (Quality: 73.6607, Cost: 57.6556). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MOHAMMAD ABUANNADI, M.D. located?
MOHAMMAD ABUANNADI, M.D. is located at 500 RAY C. HUNT DR, CHARLOTTESVILLE, VA, 22903. Phone: (434) 243-1000.
What is MOHAMMAD ABUANNADI, M.D.'s NPI number?
MOHAMMAD ABUANNADI, M.D.'s National Provider Identifier (NPI) is 1427071349, issued on 07/25/2006.
Does MOHAMMAD ABUANNADI, M.D. prescribe more brand-name or generic drugs?
MOHAMMAD ABUANNADI, M.D.'s prescribing is 22% brand-name and 78% generic drugs by claim count, with $1.0M in brand drug costs.
How many Advanced Heart Failure and Transplant Cardiology Physician providers are there in the US?
There are 510 Advanced Heart Failure and Transplant Cardiology Physician providers across 48 states in the US. The average Advanced Heart Failure and Transplant Cardiology Physician provider writes 1,762 Medicare Part D claims per year.
What drugs does MOHAMMAD ABUANNADI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MOHAMMAD ABUANNADI, M.D.'s most frequently prescribed drugs include Metoprolol Succinate, Spironolactone, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MOHAMMAD ABUANNADI, M.D. accept Medicare?
MOHAMMAD ABUANNADI, M.D. appears in CMS Medicare data with 1,946 Part D claims and 219 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MOHAMMAD ABUANNADI, M.D.'s credentials?
MOHAMMAD ABUANNADI, M.D.'s NPI is 1427071349 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology